跳至主要内容
临床试验/NCT03259191
NCT03259191Unknown不适用

Department of Gastroenterology, Zhongda Hospital

Ruihua Shi1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2017年8月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
1
主要终点
Improvement of symptoms

研究概览

简要总结

Anti-reflux mucosectomy (ARMS) may be a new therapy for refractory gastroesophageal reflux disease (RGERD). The aim of the present study is to explore the safety and efficacy of ARMS.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Full sufficiency in literacy
  • Be off proton pump inhibitor, antacids and prokinetics ≥ 2 weeks
  • Refractory gastroesophageal reflux disease

排除标准

  • Severe heart, lung, and cerebrovascular disease
  • Severe hematopoietic system disease
  • Abnormal blood coagulation function
  • Oropharyngeal abnormalities
  • Severe spine malformation
  • In pregnancy and lactation at present, or plan to become pregnant within 2 years
  • Severe inflammation or huge ulcers in stomach
  • Mental and psychological disorde

研究组 & 干预措施

completely circumferential ARMS

Other

干预措施: anti-reflux mucosectomy (Procedure)

semi-circumferential ARMS

Other

干预措施: anti-reflux mucosectomy (Procedure)

结局指标

主要结局

Improvement of symptoms

时间窗: 1 month, 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months

Improvement of all the symptoms related with RGERD.

次要结局

  • Complications of ARMS(1 month, 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months)

研究者

发起方
Ruihua Shi
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ruihua Shi

MD, PhD, Postdoctoral Mentor, Chief Physician

Zhongda Hospital

研究点 (1)

Loading locations...

相似试验